Details for New Drug Application (NDA): 061392
✉ Email this page to a colleague
NDA 061392 describes PRINCIPEN, which is a drug marketed by Apothecon and Bristol Myers Squibb and is included in nine NDAs. Additional details are available on the PRINCIPEN profile page.
The generic ingredient in PRINCIPEN is ampicillin/ampicillin trihydrate; probenecid. Additional details are available on the ampicillin/ampicillin trihydrate; probenecid profile page.
The generic ingredient in PRINCIPEN is ampicillin/ampicillin trihydrate; probenecid. Additional details are available on the ampicillin/ampicillin trihydrate; probenecid profile page.
Summary for 061392
| Tradename: | PRINCIPEN |
| Applicant: | Bristol Myers Squibb |
| Ingredient: | ampicillin/ampicillin trihydrate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 250MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 500MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
